191 related articles for article (PubMed ID: 19464991)
1. Lymphoid organs for peritoneal cavity immune response: milky spots.
Mebius RE
Immunity; 2009 May; 30(5):670-2. PubMed ID: 19464991
[TBL] [Abstract][Full Text] [Related]
2. Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens.
Rangel-Moreno J; Moyron-Quiroz JE; Carragher DM; Kusser K; Hartson L; Moquin A; Randall TD
Immunity; 2009 May; 30(5):731-43. PubMed ID: 19427241
[TBL] [Abstract][Full Text] [Related]
3. Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity.
Shimotsuma M; Shields JW; Simpson-Morgan MW; Sakuyama A; Shirasu M; Hagiwara A; Takahashi T
Lymphology; 1993 Jun; 26(2):90-101. PubMed ID: 8355522
[TBL] [Abstract][Full Text] [Related]
4. Differential molecular and anatomical basis for B cell migration into the peritoneal cavity and omental milky spots.
Berberich S; Dähne S; Schippers A; Peters T; Müller W; Kremmer E; Förster R; Pabst O
J Immunol; 2008 Feb; 180(4):2196-203. PubMed ID: 18250426
[TBL] [Abstract][Full Text] [Related]
5. Omental milky spots in the local immune response in the peritoneal cavity of rats.
Van Vugt E; Van Rijthoven EA; Kamperdijk EW; Beelen RH
Anat Rec; 1996 Feb; 244(2):235-45. PubMed ID: 8808398
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human omentum-associated lymphoid tissue components with S-100: an immunohistochemical study.
Yildirim A; Aktaş A; Nergiz Y; Akkuş M
Rom J Morphol Embryol; 2010; 51(4):759-64. PubMed ID: 21103638
[TBL] [Abstract][Full Text] [Related]
7. Expression of lymphotoxin beta governs immunity at two distinct levels.
Junt T; Tumanov AV; Harris N; Heikenwalder M; Zeller N; Kuprash DV; Aguzzi A; Ludewig B; Nedospasov SA; Zinkernagel RM
Eur J Immunol; 2006 Aug; 36(8):2061-75. PubMed ID: 16841297
[TBL] [Abstract][Full Text] [Related]
8. Cellular composition of milky spots in the human greater omentum: an immunochemical and ultrastructural study.
Krist LF; Eestermans IL; Steenbergen JJ; Hoefsmit EC; Cuesta MA; Meyer S; Beelen RH
Anat Rec; 1995 Feb; 241(2):163-74. PubMed ID: 7710133
[TBL] [Abstract][Full Text] [Related]
9. The greater omentum: physiology and immunological concepts.
Beelen RH
Neth J Surg; 1991 Oct; 43(5):145-9. PubMed ID: 1787897
[TBL] [Abstract][Full Text] [Related]
10. Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles.
McDonald KG; McDonough JS; Newberry RD
J Immunol; 2005 May; 174(9):5720-8. PubMed ID: 15843574
[TBL] [Abstract][Full Text] [Related]
11. Immune Niche Within the Peritoneal Cavity.
Okabe Y
Curr Top Microbiol Immunol; 2021; 434():123-134. PubMed ID: 34850285
[TBL] [Abstract][Full Text] [Related]
12. Specialized immune responses in the peritoneal cavity and omentum.
Liu M; Silva-Sanchez A; Randall TD; Meza-Perez S
J Leukoc Biol; 2021 Apr; 109(4):717-729. PubMed ID: 32881077
[TBL] [Abstract][Full Text] [Related]
13. Activation of omental milky spots and milky spot macrophages by intraperitoneal administration of a streptococcal preparation, OK-432.
Shimotsuma M; Simpson-Morgan MW; Takahashi T; Hagiwara A
Cancer Res; 1992 Oct; 52(19):5400-2. PubMed ID: 1394145
[TBL] [Abstract][Full Text] [Related]
14. Composition of the lymphoid cell populations from omental milky spots during the immune response in C57BL/Ka mice.
Dux K; Rouse RV; Kyewski B
Eur J Immunol; 1986 Aug; 16(8):1029-32. PubMed ID: 3488910
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in peritoneal morphology: the milky spots in peritoneal dialysis.
Garosi G; Di Paolo N
Adv Perit Dial; 2001; 17():25-8. PubMed ID: 11510287
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the omental lymphoid organ in the induction of peritoneal immunity against tumor cells.
Dullens HF; Rademakers LH; Doffemont M; Van Veen PT; Bulder R; Den Otter W
Invasion Metastasis; 1993; 13(5):267-76. PubMed ID: 7960579
[TBL] [Abstract][Full Text] [Related]
17. CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice.
Henry RA; Kendall PL
J Immunol; 2010 Aug; 185(3):1460-5. PubMed ID: 20574003
[TBL] [Abstract][Full Text] [Related]
18. Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease.
Finch DK; Ettinger R; Karnell JL; Herbst R; Sleeman MA
Eur J Clin Invest; 2013 May; 43(5):501-9. PubMed ID: 23517338
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes in the peritoneum home to the omentum and are activated by resident dendritic cells.
Carlow DA; Gold MR; Ziltener HJ
J Immunol; 2009 Jul; 183(2):1155-65. PubMed ID: 19553538
[TBL] [Abstract][Full Text] [Related]
20. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.
Gommerman JL; Browning JL
Nat Rev Immunol; 2003 Aug; 3(8):642-55. PubMed ID: 12974479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
